NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
TMS and Eating Disorders: A New Approach to Treatment
Eating disorders such as anorexia nervosa and bulimia nervosa are complex conditions that often resist traditional treatments. Characterized by obsessive [...]
TMS for Cognitive Enhancement at Countryside Neurology
In today's fast-paced world, cognitive enhancement has become a hot topic. The desire to sharpen memory, boost attention, and improve [...]
Exploring TMS for Bipolar Disorder: Can It Help Stabilize Mood Swings?
Bipolar Disorder is characterized by extreme mood swings that include emotional highs (mania or hypomania) and lows (depression). Managing these [...]
TMS Therapy for Epilepsy: Potential Benefits and Research
Exploring TMS as a Revolutionary Treatment for Epilepsy Living with epilepsy can be incredibly challenging, especially when seizures are not [...]
TMS and Stroke Rehabilitation: Promising Outcomes
Unlocking Recovery Potential with TMS Therapy Stroke can be a life-altering event, leaving individuals with significant physical and cognitive impairments. [...]
Using TMS to Treat Parkinson’s Disease Symptoms
Parkinson’s Disease is a progressive neurodegenerative disorder that affects movement and often includes symptoms like tremors, rigidity, and depression. Managing [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social